Valeant, Ackman Eye Allergan Board Shake-Up Amid $46B Bid
Deal-happy drugmaker Valeant Pharmaceuticals International Inc. said Thursday that it would pursue a campaign to reshape the board of Botox maker Allergan Inc., the company it is targeting alongside activist investor...To view the full article, register now.
Already a subscriber? Click here to view full article